Prof. Dr. Ayhan SAVAŞER

Yayın Ağı

Makaleler 63

1. CHROMATOGRAPHIC AND COMPUTATIONAL APPROACHES TO THE PHARMACOKINETIC PROFILE OF PIROXICAM AND ITS SENSITIVE ASSAY IN RABBIT PLASMA TAVŞAN PLAZMASINDA PİROKSİKAMİN FARMAKOKİNETİK PROFİLİNE VE HASSAS ANALİZİNE YÖNELİK KROMATOGRAFİK VE HESAPLAMALI YAKLAŞIMLAR

AKSOY O. A., Taskin-Tok T., Cotaoglu M. Z., KARADAŞ BAKIRHAN N., KOÇAK E., Göksel B. A., et al.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.50, sa.2, ss.350-361, 2026 (Scopus, TRDizin)

2. BSA-Based Nanoparticles for Dual Loading of Pazopanib and Enzalutamide: Formulation Optimization and In Vitro Evaluation in Breast Cancer Cells

TOPAL G. R., KILIÇ K., Sarper M., EŞİM Ö., SAVAŞER A., ÖZKAN Y.

Pharmaceutics , cilt.18, sa.4, 2026 (SCI-Expanded, Scopus)

3. Targeted hepatic delivery of ezetimibe via red blood cell-coated nanoparticles for the treatment of non-alcoholic fatty liver disease through inflammation modulation

EŞİM Ö., ADATEPE Ş., AKSOY O. A., Goksel B. A., Yilmaz T., BAYKAL B., et al.

International Journal of Pharmaceutics , cilt.685, 2025 (SCI-Expanded, Scopus)

4. Design and optimization of olaparib nanostructured lipid carriers for breast cancer treatment

TOPAL G. R., EŞİM Ö., Sarper M., KÖSE ÖZKAN C., KARADAŞ BAKIRHAN N., Atici E. B., et al.

Therapeutic Delivery , cilt.16, sa.10, ss.939-950, 2025 (ESCI, Scopus)

5. Metabolomic profiles altered by erlotinib encapsulated in poly(lactide-co-glycolide) nanoparticles in non-small cell lung cancer

YÜCEL Ç., EŞİM Ö., KARADAŞ BAKIRHAN N., ERDOĞAN KABLAN S., KOÇAK E., ERTUĞRUL M. S., et al.

Drug Development and Industrial Pharmacy , cilt.51, sa.5, ss.467-476, 2025 (SCI-Expanded, Scopus)

6. PREPARATION AND IN VIVO EVALUATION OF PIROXICAM SUBGLINGUAL POLYMERIC FILMS PİROKSİKAM DİLALTI POLİMERİK FİLMLERİNİN HAZIRLANMASI VE İN VİVO DEĞERLENDİRİLMESİ

AKSOY O. A., ZANBAK ÇOTAOĞLU E. M., TOPAL G. R., Göksel B. A., EŞİM Ö., KÖSE ÖZKAN C., et al.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.48, sa.3, ss.1128-1134, 2024 (Scopus, TRDizin)

7. The potential role of hot flashes treatment strategies and regorafenib combinations in breast cancer therapy via co-drug loaded polymeric nanoparticles

EŞİM Ö., ADATEPE Ş., Sarper M., KARADAŞ BAKIRHAN N., ERDOĞAN KABLAN S., KOÇAK E., et al.

Journal of Drug Delivery Science and Technology , cilt.98, 2024 (SCI-Expanded, Scopus)

8. Definition of Design Space for Preparation and Stability of Tramadol Hydrochloride Loaded Nanoparticles Using OFAT Experiments for Infusion in Pain Management

Yildirim N., SAVAŞER A., EŞİM Ö., TOPAL G. R., KÖSE ÖZKAN C., ÖZKAN Y.

Journal of Cluster Science , cilt.35, sa.6, ss.1797-1807, 2024 (SCI-Expanded, Scopus)

9. Design, characterization, and evaluation of a polymeric nanofiber system for sublingual delivery of aceclofenac: A promising approach for enhanced pain management

KÖSE ÖZKAN C., TORT S., AKSOY O. A., ZANBAK ÇOTAOĞLU E. M., EŞİM Ö., SAVAŞER A., et al.

Journal of Drug Delivery Science and Technology , cilt.88, 2023 (SCI-Expanded, Scopus)

10. The Power of Carbon Nanotubes on Sensitive Drug Determination Methods

KARADAŞ BAKIRHAN N., KAYA S. İ., Jabbarov R., Gahramanova G., Abdullayeva S., Dedeoglu A., et al.

Critical Reviews in Analytical Chemistry , cilt.53, sa.2, ss.374-383, 2023 (SCI-Expanded, Scopus)

11. Preparation of Piroxicam nanosuspensions by high pressure homogenization and evaluation of improved bioavailability

AKSOY O. A., ZANBAK ÇOTAOĞLU E. M., Fatsa T., TOPAL G. R., EŞİM Ö., Göksel B. A., et al.

Drug Development and Industrial Pharmacy , cilt.49, sa.12, ss.715-722, 2023 (SCI-Expanded, Scopus)

12. Ocjena apsorpcije, djelotvornosti protiv bakterije Escherichia coli i citotoksičnosti krutih lipidnih nanočestica s moksifloksacinom Evaluation of bacterial uptake, antibacterial efficacy against Escherichia coli, and cytotoxic effects of moxifloxacin-loaded solid lipid nanoparticles

BOZKURT M. E., TOPAL G. R., EŞİM Ö., GÜDÜL BACANLI M., KÖSE ÖZKAN C., ERDEM O., et al.

Arhiv za Higijenu Rada i Toksikologiju , cilt.73, sa.4, ss.260-269, 2022 (SCI-Expanded, Scopus)

13. Current trends in nanomaterials: Drug delivery and their sensitive assays

EŞİM Ö., SAVAŞER A.

Current Drug Delivery , cilt.18, sa.2, ss.102, 2021 (SCI-Expanded, Scopus)

14. An overview of excipients classification and their use in pharmaceuticals

KÖSE ÖZKAN C., EŞİM Ö., SAVAŞER A., ÖZKAN Y.

Current Pharmaceutical Analysis , cilt.17, sa.3, ss.360-374, 2021 (SCI-Expanded, Scopus)

15. Current status of drug delivery approaches and assay of anti-migraine drugs

EŞİM Ö., SAVAŞER A., Karadurmus L., KARADAŞ BAKIRHAN N., ÖZKAN S. A., ÖZKAN Y.

Current Drug Delivery , cilt.18, sa.2, ss.121-146, 2021 (SCI-Expanded, Scopus)

16. Development, optimization and in vitro evaluation of oxaliplatin loaded nanoparticles in non-small cell lung cancer

EŞİM Ö., KARADAŞ BAKIRHAN N., Yildirim N., Sarper M., SAVAŞER A., ÖZKAN S. A., et al.

DARU, Journal of Pharmaceutical Sciences , cilt.28, sa.2, ss.673-684, 2020 (SCI-Expanded, Scopus)

17. Influence of emulsifiers on the formation and in vitro anticancer activity of epirubicin loaded PLGA nanoparticles

EŞİM Ö., KARADAŞ BAKIRHAN N., Sarper M., SAVAŞER A., ÖZKAN S. A., ÖZKAN Y.

Journal of Drug Delivery Science and Technology , cilt.60, 2020 (SCI-Expanded, Scopus)

18. Nose to brain delivery of eletriptan hydrobromide nanoparticles: Preparation, in vitro/in vivo evaluation and effect on trigeminal activation

EŞİM Ö., SAVAŞER A., KÖSE ÖZKAN C., Oztuna A., Goksel B. A., ÖZLER M., et al.

Journal of Drug Delivery Science and Technology , cilt.59, 2020 (SCI-Expanded, Scopus)

19. In vitro evaluation of two different types of obidoxime-loaded nanoparticles for cytotoxicity and blood-brain barrier transport

SEZİGEN S., EŞİM Ö., Sarper M., SAVAŞER A.

Toxicology Letters , cilt.330, ss.53-58, 2020 (SCI-Expanded, Scopus)

20. Effect simultaneous delivery with P-glycoprotein inhibitor and nanoparticle administration of doxorubicin on cellular uptake and in vitro anticancer activity

EŞİM Ö., Sarper M., KÖSE ÖZKAN C., Oren S., BAYKAL B., SAVAŞER A., et al.

Saudi Pharmaceutical Journal , cilt.28, sa.4, ss.465-472, 2020 (SCI-Expanded, Scopus)

21. NH2-fMWCNT-titanium dioxide nanocomposite based electrochemical sensor for the voltammetric assay of antibiotic drug nadifloxacin and its in vitro permeation study

Aftab S., KARADAŞ BAKIRHAN N., EŞİM Ö., Shah A., SAVAŞER A., ÖZKAN Y., et al.

Journal of Electroanalytical Chemistry , cilt.859, 2020 (SCI-Expanded, Scopus)

22. In vitro and in vivo evaluation of linezolid loaded electrospun PLGA and PLGA/PCL fiber mats for prophylaxis and treatment of MRSA induced prosthetic infections

EREN BÖNCÜ T., Uskudar Guclu A., Catma M. F., SAVAŞER A., Gokce A., Ozdemir N.

International Journal of Pharmaceutics , cilt.573, 2020 (SCI-Expanded, Scopus)

23. Investigation of the mucoadhesivity, swelling, and drug release mechanisms of indomethacin buccal tablets: effect of formulation variables

EŞİM Ö., SAVAŞER A., KÖSE ÖZKAN C., Tas C., ÖZKAN Y.

Drug Development and Industrial Pharmacy , cilt.46, sa.12, ss.1979-1987, 2020 (SCI-Expanded, Scopus)

24. Stability-indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe from pharmaceuticals and biological samples

KURBANOĞLU S., EŞİM Ö., KÖSE ÖZKAN C., SAVAŞER A., ÖZKAN Y., USLU B., et al.

Journal of the Turkish Chemical Society, Section A: Chemistry , cilt.7, sa.3, ss.865-874, 2020 (Scopus, TRDizin)

25. Development of gemcitabine loaded plga/lecithin nanoparticles for non-small cell lung cancer therapy

EŞİM Ö., K.ozkan C., Sarper M., SAVAŞER A., ÖZKAN Y.

Current Drug Delivery , cilt.17, sa.7, ss.622-628, 2020 (SCI-Expanded, Scopus)

26. Development and in vitro/in vivo evaluation of dihydroergotamine mesylate loaded maltodextrin-pullulan sublingual films

EŞİM Ö., KÖSE ÖZKAN C., KURBANOĞLU S., Arslan A., Tas C., SAVAŞER A., et al.

Drug Development and Industrial Pharmacy , cilt.45, sa.6, ss.914-921, 2019 (SCI-Expanded, Scopus)

27. Development and Validation of RP-LC Method for the Simultaneous Determination of Simvastatin and Ezetimibe in Fixed-Dose Combination Tablets and in Rabbit Serum

KURBANOĞLU S., EŞİM Ö., KÖSE ÖZKAN C., SAVAŞER A., ÖZKAN Y., ÖZKAN S. A.

Chromatographia , cilt.82, sa.1, ss.279-285, 2019 (SCI-Expanded, Scopus)

28. Evaluation of a novel oxiconazole nitrate formulation: The thermosensitive gel

Arslan A., KÖSE ÖZKAN C., SIĞ A. K., Dogan E., EŞİM Ö., ÇETİNKAYA S., et al.

Saudi Pharmaceutical Journal , cilt.26, sa.5, ss.665-672, 2018 (SCI-Expanded, Scopus)

29. Effect of polymer type on characteristics of buccal tablets using factorial design

EŞİM Ö., SAVAŞER A., KÖSE ÖZKAN C., Bayrak Z., Tas C., ÖZKAN Y.

Saudi Pharmaceutical Journal , cilt.26, sa.1, ss.53-63, 2018 (SCI-Expanded, Scopus)

30. Development of assay for determination of eletriptan hydrobromide in loaded PLGA nanoparticles

EŞİM Ö., SAVAŞER A., KURBANOĞLU S., KÖSE ÖZKAN C., ÖZKAN S. A., ÖZKAN Y.

Journal of Pharmaceutical and Biomedical Analysis , cilt.142, ss.74-83, 2017 (SCI-Expanded, Scopus)

31. Fulvestrant-loaded polymer-based nanoparticles for local drug delivery: Preparation and in vitro characterization

HASÇİÇEK C., ŞENGEL TÜRK C. T., GÜMÜŞTAŞ M., ÖZKAN S. A., BAKAR ATEŞ F., Das-Evcimen N., et al.

Journal of Drug Delivery Science and Technology , cilt.40, ss.73-82, 2017 (SCI-Expanded, Scopus)

32. Simultaneous Determination and Drug Dissolution Testing of Combined Amlodipine Tablet Formulations Using RP-LC

KÖSE ÖZKAN C., KURBANOĞLU S., EŞİM Ö., SAVAŞER A., ÖZKAN S. A., ÖZKAN Y.

Chromatographia , cilt.79, sa.17-18, ss.1143-1151, 2016 (SCI-Expanded, Scopus)

33. Evaluation of freezing effect on stability of large volume parenteral products Büyük hacimli parenteral çözeltilerde donmanin stabilite üzerine etkisinin değerlendirilmesi

Safi A., KÖSE ÖZKAN C., EŞİM Ö., Bayrak Z., Taş Ç., SAVAŞER A., et al.

Gulhane Medical Journal , cilt.58, sa.3, ss.261-265, 2016 (Scopus, TRDizin)

34. Influence of polymer molecular weight on in-vitro characteristics and cytotoxicity of fulvestrant loaded nanoparticles

HASÇİÇEK C., ŞENGEL TÜRK C. T., GÜMÜŞTAŞ M., ÖZKAN S. A., BAKAR ATEŞ F., Das-Evcimen N., et al.

Current Drug Therapy , cilt.9, sa.4, ss.239-249, 2015 (Scopus) Sürdürülebilir Kalkınma

35. LC-MS method for the sensitive determination of metoclopramide: Application to rabbit plasma, gel formulations and pharmaceuticals

Bayrak Z., KURBANOĞLU S., SAVAŞER A., ÖZKAN S. A., ALTUNAY H., Tas C., et al.

Chromatographia , cilt.77, sa.1-2, ss.99-107, 2014 (SCI-Expanded, Scopus)

36. Determination of dimenhydrinate nasal delivery system in the blood by RP-LC

KÖSE ÖZKAN C., TAŞDEMİR U., Taş Ç., SAVAŞER A., Erol H., ÖZKAN Y.

Chromatographia , cilt.76, sa.21-22, ss.1521-1525, 2013 (SCI-Expanded, Scopus)

37. Effect of different polymers and their combinations on the release of metoclopramide HCl from sustained-release hydrophilic matrix tablets

SAVAŞER A., Taş Ç., Bayrak Z., KÖSE ÖZKAN C., ÖZKAN Y.

Pharmaceutical Development and Technology , cilt.18, sa.5, ss.1122-1130, 2013 (SCI-Expanded, Scopus)

38. Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: In vitro and in vivo evaluation

Bayrak Z., Tas C., TAŞDEMİR U., Erol H., KÖSE ÖZKAN C., SAVAŞER A., et al.

European Journal of Pharmaceutics and Biopharmaceutics , cilt.78, sa.3, ss.499-505, 2011 (SCI-Expanded, Scopus)

39. The development and in vitro evaluation of sustained release tablet formulations of benzydamine hydrochloride and its determination

KÖSE ÖZKAN C., SAVAŞER A., Tas C., ÖZKAN Y.

Combinatorial Chemistry and High Throughput Screening , cilt.13, sa.8, ss.683-689, 2010 (SCI-Expanded, Scopus)

40. Nasal administration of metoclopramide from different dosage forms: In vitro, ex vivo, and in vivo evaluation

Tas C., KÖSE ÖZKAN C., SAVAŞER A., ÖZKAN Y., TAŞDEMİR U., Altunay H.

Drug Delivery , cilt.16, sa.3, ss.167-175, 2009 (SCI-Expanded, Scopus)

41. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer

Arsova-Sarafinovska Z., EKEN A., Matevska N., ERDEM O., Sayal A., SAVAŞER A., et al.

Clinical Biochemistry , cilt.42, sa.12, ss.1228-1235, 2009 (SCI-Expanded, Scopus)

42. Effect of intraoperative magnesium sulphate infusion on pain relief after laparoscopic cholecystectomy

Mentes O., Harlak A., Yigit T., Balkan A., Balkan M., COŞAR A., et al.

Acta Anaesthesiologica Scandinavica , cilt.52, sa.10, ss.1353-1359, 2008 (SCI-Expanded, Scopus)

43. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers

Tas C., ÖZKAN Y., OKYAR A., SAVAŞER A.

Drug Delivery , cilt.14, sa.7, ss.453-459, 2007 (SCI-Expanded, Scopus)

44. Determination of abacavir, lamivudine and zidovudine in pharmaceutical tablets, human serum and in drug dissolution studies by HPLC

SAVAŞER A., Goraler S., Taşöz A., USLU B., Lingeman H., ÖZKAN S. A.

Chromatographia , cilt.65, sa.5-6, ss.259-265, 2007 (SCI-Expanded, Scopus)

45. Rapid and simple determination of plasma and erythrocyte MDA levels in prostate cancer patients by a validated HPLC method

Arsova-Sarafinovska Z., Aydin A., Sayal A., EKEN A., ERDEM O., SAVAŞER A., et al.

Journal of Liquid Chromatography and Related Technologies , cilt.30, sa.16, ss.2435-2444, 2007 (SCI-Expanded, Scopus)

46. Enhancement of ketoprofen bioavailability by formation of microsponge tablets

ÇOMOĞLU T., SAVAŞER A., ÖZKAN Y., Gönül N., Baykara T.

Pharmazie , cilt.62, sa.1, ss.51-54, 2007 (SCI-Expanded, Scopus)

47. Nasal absorption of metoclopramide from different Carbopol® 981 based formulations: In vitro, ex vivo and in vivo evaluation

Tas C., KÖSE ÖZKAN C., SAVAŞER A., ÖZKAN Y., TAŞDEMİR U., Altunay H.

European Journal of Pharmaceutics and Biopharmaceutics , cilt.64, sa.2, ss.246-254, 2006 (SCI-Expanded, Scopus)

48. Long-term methylphenidate treatment causes increased superoxide dismutase activity and unchanged lipid peroxidation in rat brain

CÖNGÖLOĞLU M. A., Türkbay T., Doruk A., Topal T., SAVAŞER A., Aydin A.

Klinik Psikofarmakoloji Bulteni , cilt.16, sa.2, ss.79-83, 2006 (Scopus, TRDizin)

49. Simple and reliable HPLC method of abacavir determination in pharmaceuticals, human serum and drug dissolution studies from tablets

ÖZKAN Y., SAVAŞER A., ÖZKAN S. A.

Journal of Liquid Chromatography and Related Technologies , cilt.28, sa.3, ss.423-437, 2005 (Scopus)

50. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium

SAVAŞER A., ÖZKAN Y., Işimer A.

Farmaco , cilt.60, sa.2, ss.171-177, 2005 (Scopus)

51. Validated RP-HPLC method for the assay of zalcitabine in drug substance, formulated products and human serum

USLU B., SAVAŞER A., ÖZKAN S. A., ÖZKAN Y.

Pharmazie , cilt.59, sa.8, ss.604-607, 2004 (Scopus)

52. In vitro and ex vivo permeation studies of chlorpheniramine maleate gels prepared by carbomer derivatives

Taş Ç., ÖZKAN Y., SAVAŞER A., Baykara T.

Drug Development and Industrial Pharmacy , cilt.30, sa.6, ss.637-647, 2004 (Scopus)

53. Validated LC determination of the piroxicam-β-cyclodextrin inclusion complex in tablets and in human plasma

SAVAŞER A., KARATAŞ A., ÖZKAN Y., YÜKSEL N., ÖZKAN S. A., Baykara T.

Chromatographia , cilt.59, sa.9-10, ss.555-560, 2004 (Scopus)

54. RP-HPLC Assay of Rofecoxib from Pharmaceutical Dosage Forms and Human Plasma and Its Drug Dissolution Studies

SAVAŞER A., ÖZKAN Y., KÖSE ÖZKAN C., Taş Ç., ÖZKAN S. A.

Analytical Letters , cilt.37, sa.1, ss.81-97, 2004 (Scopus)

55. Drug dissolution studies and determination of deflazacort in pharmaceutical formulations and human serum samples by RP-HPLC

ÖZKAN Y., SAVAŞER A., Taş Ç., USLU B., ÖZKAN S. A.

Journal of Liquid Chromatography and Related Technologies , cilt.26, sa.13, ss.2141-2156, 2003 (Scopus)

56. In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives

Tas Ç., ÖZKAN Y., SAVAŞER A., Baykara T.

Farmaco , cilt.58, sa.8, ss.605-611, 2003 (Scopus)

57. Development and validation of an RP-HPLC method for the determination of valacyclovir in tablets and human serum and its application to drug dissolution studies

SAVAŞER A., KÖSE ÖZKAN C., ÖZKAN Y., USLU B., ÖZKAN S. A.

Journal of Liquid Chromatography and Related Technologies , cilt.26, sa.11, ss.1755-1767, 2003 (Scopus)

58. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: In vitro and in vivo evaluation

YÜKSEL N., KARATAŞ A., ÖZKAN Y., SAVAŞER A., ÖZKAN S. A., Baykara T.

European Journal of Pharmaceutics and Biopharmaceutics , cilt.56, sa.3, ss.453-459, 2003 (SCI-Expanded, Scopus)

59. Comparative dissolution testing of paracetamol commercial tablet dosage forms

ÖZKAN Y., Özalp Y., SAVAŞER A., ÖZKAN S. A.

Acta Poloniae Pharmaceutica - Drug Research , cilt.57, sa.1, ss.33-41, 2000 (Scopus)

60. Dissolution properties of different designed and formulated salbutamol tablet dosage forms

ÖZKAN Y., SAVAŞER A., Ozalp Y., Isimer A.

Acta Poloniae Pharmaceutica - Drug Research , cilt.57, sa.4, ss.271-276, 2000 (Scopus)

61. Evaluation of chitosan used as an excipient in tablet formulations

Kepsutlu A. R., SAVAŞER A., ÖZKAN Y., Dikmen N., Işimer A.

Acta Poloniae Pharmaceutica - Drug Research , cilt.56, sa.3, ss.227-235, 1999 (Scopus)

62. In-vitro quality control study of paracetamol containing tablets in Turkish drug market

ÖZKAN Y., Özalp Y., SAVAŞER A., ÖZKAN S. A.

Journal de Pharmacie de Belgique , cilt.53, sa.3, ss.233, 1998 (Scopus)

63. Pharmaceutical quality controls and dissolution rates of izoniazid tablet formulations IZONIAZID TABLET FORMULASYONLARININ FARMASOTIK KALITE KONTROLLERI VE COZUNME HIZLARI

SAVAŞER A., ÖZKAN Y., Cevheroglu S., Isimer A., Dikmen N.

Bulletin of Gulhane Military Medical Academy , cilt.38, sa.3, ss.304-310, 1996 (Scopus)

Kitaplar 5

1. An Up-to-Date Look at In Vitro Models of Nose-to-Brain Drug Delivery

KÖSE ÖZKAN C., EŞİM Ö., SAVAŞER A.

Nanomaterials for Cancer Detection Using Imaging Techniques and Their Clinical Applications, Springer International Publishing Ag, ss.115-139, 2022

2. Progresses on Polymer Nanocomposites: Drug Delivery Systems and Sensitive Detections

Karadurmus L., EŞİM Ö., KARADAŞ BAKIRHAN N., SAVAŞER A., ÖZKAN Y., ÖZKAN S. A.

Handbook of Polymer and eramic Nanotechnology: Volume 1,2, Springer International Publishing Ag, ss.381-401, 2021

3. Biocompatible Nanopolymers in Drug Delivery Systems and Their Recent Electrochemical Applications in Drug Assays

ÖZÇELİKAY AKYILDIZ G., EŞİM Ö., KARADAŞ BAKIRHAN N., SAVAŞER A., ÖZKAN Y., ÖZKAN S. A.

Handbook of Polymer and eramic Nanotechnology: Volume 1,2, Springer International Publishing Ag, ss.875-894, 2021

4. Nanomaterials for drug delivery systems

EŞİM Ö., KURBANOĞLU S., SAVAŞER A., ÖZKAN S. A., ÖZKAN Y.

New Developments in Nanosensors for Pharmaceutical Analysis, Elsevier, ss.273-301, 2019

5. Current perspectives on drug release studies from polymeric nanoparticles

SAVAŞER A., EŞİM Ö., KURBANOĞLU S., ÖZKAN S. A., ÖZKAN Y.

Organic Materials as Smart Nanocarriers for Drug Delivery, Elsevier, ss.101-145, 2018

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

1476

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler